Viewing Study NCT05925803

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:25 PM
Ignite Modification Date: 2026-07-06 @ 6:35 AM
Study NCT ID: NCT05925803
Status: RECRUITING
Last Update Posted: 2025-11-21
First Post: 2023-06-02
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Systemic Sclerosis View
None Scleroderma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Systemic Sclerosis (SSc) View
None Scleroderma View
None Anifrolumab View
None Limited View
None Diffuse View
None Cutaneous View
None Interstitial lung disease (ILD) View
None Autoimmune diseases View
None Immune system diseases View
None Immunosuppressants View
None Systemic Sclerosis interstitial lung disease (SSc- ILD) View